Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis

被引:104
|
作者
Thomsen, Michael [1 ]
Vitetta, Luis [1 ,2 ]
机构
[1] Univ Sydney, Sydney, NSW, Australia
[2] Medlab Clin Ltd, 66 McCauley St, Sydney, NSW 2015, Australia
基金
英国医学研究理事会;
关键词
chemotherapy; radiotherapy; mucositis; diarrhea; probiotics; adjunctive compounds; INDUCED ORAL MUCOSITIS; PLACEBO-CONTROLLED TRIAL; RANDOMIZED DOUBLE-BLIND; NECK-CANCER PATIENTS; RADIATION-INDUCED ESOPHAGITIS; HIGH-DOSE CHEMOTHERAPY; COLORECTAL-CANCER; INDUCED DIARRHEA; ZINC-SULFATE; MANUKA HONEY;
D O I
10.1177/1534735418794885
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Chemoradiotherapy-associated mucositis can manifest as pain, inflammation, dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose-limiting side effect of chemotherapy, affecting nutritional intake and oral and intestinal function. Despite several interventions being available, there is a need for safe and effective preventative and treatment options for treatment-induced mucositis. The goals of this review are to discuss interventions based on foods and natural products and present the research to date. Methods: A narrative literature review identified 60 clinical studies examining various nutritional compounds and 20 examining probiotics. 9 studies on probiotics for the prevention of diarrhea were also assessed on methodological quality and limitations identified. Results: Several compounds have been posited as useful adjuvants for cancer treatment-related mucositis. Probiotics demonstrate efficacy for the prevention and treatment of chemoradiotherapy-induced gastrointestinal toxicity without significant side effects. Glutamine and activated charcoal were reported to reduce chemotherapy-induced diarrhea but not radiation-induced intestinal mucositis. Honey has been reported to decrease treatment interruptions, weight loss, and delays the onset of oral mucositis. Zinc, glutamine, and topical vitamin E were demonstrated efficacy for oral mucositis. Conclusion: There is plausible clinical evidence for the administration of several adjunctive treatments for the prevention and treatment of mucositis. Probiotics were reported to reduce the burden of intestinal mucositis and treatment-induced diarrhea. Activated charcoal and glutamine are beneficial for chemotherapy-induced diarrhea, whereas the administration of honey, zinc, and glutamine reduce the risk of developing oral mucositis during chemotherapy or radiotherapy.
引用
收藏
页码:1027 / 1047
页数:21
相关论文
共 50 条
  • [21] Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor
    Beck, PL
    Wong, JF
    Li, Y
    Swaminathan, S
    Xavier, RJ
    Devaney, KL
    Podolsky, DK
    GASTROENTEROLOGY, 2004, 126 (03) : 796 - 808
  • [22] Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
    Roila, F.
    Herrstedt, J.
    Aapro, M.
    Gralla, R. J.
    Einhorn, L. H.
    Ballatori, E.
    Bria, E.
    Clark-Snow, R. A.
    Espersen, B. T.
    Feyer, P.
    Grunberg, S. M.
    Hesketh, P. J.
    Jordan, K.
    Kris, M. G.
    Maranzano, E.
    Molassiotis, A.
    Morrow, G.
    Olver, I.
    Rapoport, B. L.
    Rittenberg, C.
    Saito, M.
    Tonato, M.
    Warr, D.
    ANNALS OF ONCOLOGY, 2010, 21 : v232 - v243
  • [23] Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemotherapy- and/or Radiotherapy-Induced Mucositis: A Randomized Double-Blinded Study
    Vayne-Bossert, Petra
    Escher, Monica
    de Vautibault, Caroline Gilbert
    Dulguerov, Pavel
    Allal, Abdelkarim
    Desmeules, Jules
    Herrmann, Francois R.
    Pautex, Sophie
    JOURNAL OF PALLIATIVE MEDICINE, 2010, 13 (02) : 125 - 128
  • [24] Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
    Rey, J. -B.
    Launay-Vacher, V.
    Scotte, F.
    Krakowski, I.
    Aapro, M.
    ONCOLOGIE, 2012, 14 (05) : 329 - 342
  • [25] Three photobiomodulation protocols in the prevention/treatment of radiotherapy-induced oral mucositis
    de Carvalho, Paulo Andre Gonsalves
    Lessa, Roberta Cardim
    Carraro, Dirce Maria
    Pellizzon, Antonio Cassio Assis
    Jaguar, Graziella Chagas
    Alves, Fabio A.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 31
  • [26] Alleviation of radiotherapy-induced oral mucositis
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (12): : E664 - E664
  • [27] Efficacy and Safety of ior®EPOCIM for Chemotherapy- or Radiotherapy-Induced Anemia in Pediatric Cancer Patients
    Vargas, Alicia
    Mendoza, Ivis
    Uranga, Rolando
    Gonzalez, Alejandro
    Martinez, Liliana
    Caballero, Iraida
    Piedra, Patricia
    Saurez, Giselle
    Verdecia, Manuel
    Cabanas, Ricardo
    MEDICC REVIEW, 2010, 12 (03) : 27 - 31
  • [28] Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
    Daugelaite, Goda
    Uzkuraityte, Kriste
    Jagelaviciene, Egle
    Filipauskas, Aleksas
    MEDICINA-LITHUANIA, 2019, 55 (02):
  • [29] Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
    Blijlevens, N.
    Sonis, S.
    ANNALS OF ONCOLOGY, 2007, 18 (05) : 817 - 826
  • [30] 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
    Roila, F.
    Molassiotis, A.
    Herrstedt, J.
    Aapro, M.
    Gralla, R. J.
    Bruera, E.
    Clark-Snow, R. A.
    Dupuis, L. L.
    Einhorn, L. H.
    Feyer, P.
    Hesketh, P. J.
    Jordan, K.
    Olver, I.
    Rapoport, B. L.
    Roscoe, J.
    Ruhlmann, C. H.
    Walsh, D.
    Warr, D.
    van der Wetering, M.
    ANNALS OF ONCOLOGY, 2016, 27 : v119 - v133